About Us

Warnex is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical sector.

Warnex Analytical Services provides a variety of quality control services, including traditional chemistry, microbiology, chromatography and stability testing, as well as method development and validation, to clients in the pharmaceutical and biotechnology industries.

Warnex Bioanalytical Services conducts bioavailability and bioequivalence studies for clinical trials, and performs contract R&D for clients in the pharmaceutical and biotechnology industries.

Warnex was founded on and remains committed to a business philosophy that reduces risk while building long-term shareholder value. Our goal is to grow our laboratory services divisions both organically and through acquisitions.

The Company’s shares are traded on the Toronto Stock Exchange (TSX) under the symbol WNX.

Stock Quote

TSX: WNX   High: 0.02
Open: 0.02 Low: 0.02
Canadian $    Quotes are delayed.


2010 Annual Report (PDF: 643 Kb)
Corporate presentation (PDF: 3.43 Mb)

Latest News

March 2, 2012
Warnex Extends Maturity Date of its Outstanding Debentures and Provides Update on its Listing Status
February 14, 2012
Warnex Suspends Sale of Analytical Services Division